Navigation Links
MedeAnalytics Releases Analysis of Public Comments on ACO Proposed Rule
Date:6/13/2011

EMERYVILLE, Calif., June 13, 2011 /PRNewswire/ -- MedeAnalytics, a leading provider of healthcare performance management solutions, disseminated today a report which analyzes the leading healthcare constituencies' recommendations on the major factors of the accountable care organization (ACO) economic model as presented in the proposed rule for the Medicare Shared Savings Program.

(Logo:  http://photos.prnewswire.com/prnh/20100621/SF23660LOGO)

The proposed rule was released on March 31, 2011, and the public comment period ended on June 6, 2011. The MedeAnalytics report identifies nine elements of the program that function as the primary drivers of the Medicare ACO business model. In addition, it presents the respective positions on these elements of seven nationally recognized healthcare constituencies: the American Hospital Association, the Federation of American Hospitals, the American Medical Association, the American Medical Group Association, the Medical Group Management Association, America's Health Insurance Plans, and Brookings-Dartmouth.

"While there has been some rhetoric in the media about scrapping the entire ACO program as laid out by the proposed rule, the seven constituent organizations presented recommendations to revise, not repeal, the program," commented Ken Perez, who directs MedeAnalytics' healthcare policy team and serves as the company's senior vice president of marketing.

All seven organizations recommended a significant reduction to the 65 quality measures in the proposed rule (with the 32 measures of the Physician Group Practice Demonstration often cited as a preferred measure set), as well as a gradual phase-in period. A majority of the organizations urged the Centers for Medicare & Medicaid Services (CMS) to make the financial terms of the ACO program more attractive, with calls for a standard, flat Minimum Savings Rate, increases to the maximum shared savings rate, the elimination of withholding of a portion of the earned performance payment by CMS, and creation of a separate model without downside risk.  

To download the complete report, including a table summarizing the recommendations of the seven organizations for the major financial aspects of the proposed rule, visit MedeAnalytics' ACO Resource Center at www.medeanalytics.com/aco.

About MedeAnalytics

Founded in 1994, MedeAnalytics delivers performance management solutions across the healthcare system—including hospitals, physician practices and payers—to ensure accountability and improve financial, operational and clinical outcomes. For more information, visit www.medeanalytics.com.

For more information:
Bruce Lewis
Lewis & Summers Public Relations
(707) 813-1197
bruce@prwebsite.com


'/>"/>
SOURCE MedeAnalytics
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. ACO Proposed Rule Simplified: MedeAnalytics Releases Comprehensive White Paper
2. Unprecedented international meeting releases preliminary vision for our energy future
3. ClearCanvas Releases First Commercial Version of Widely Used PACS; Integrated RIS/PACS to Follow
4. Announcement - Clontech Laboratories, Inc. Releases the iDimerize™ Cell Signaling and Expression Systems
5. ClearCanvas Releases First Commercial Version of Popular Clinical Radiology Workstation; PACS and RIS to Follow
6. BioLegend Releases Brilliant Violet 421™ Antibody Conjugates For Advanced Flow Cytometry Applications.
7. Clontech Laboratories, Inc. Releases the SMARTer™ Ultra Low RNA Kit for Illumina® Sequencing
8. OriGene Releases Bioactive Full-length Human MTOR Protein
9. Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2011
10. Waters Releases NuGenesis SDMS 7.1 Validated to Support Windows 7 and Empower 3 CDS
11. OriGene Releases 1500 TrueMAB™ Monoclonal Antibodies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... CA (PRWEB) , ... April 29, 2016 , ... Summit ... (NSCF) to support the development of a patient-specific stem cell therapy for the treatment ... the lab of Dr. Jeanne Loring at The Scripps Research Institute in San Diego, ...
(Date:4/29/2016)... 29, 2016 Elekta is pleased ... to its industry-leading treatment planning software, is available for ... Monaco version 5.11 provides significant performance speed ... speeds up to four times faster than in previous ... industry,s gold standard Monte Carlo ...
(Date:4/28/2016)... Q BioMed Inc. (OTCQB:QBIO), ...  was featured in an article he wrote on ... To Tread: http://www.lifescienceleader.com/doc/accelerators-enter-when-vcs-fear-to-tread-0001 ... an essential business journal for life science executives ... Big Pharmas. Their content is designed to inform ...
(Date:4/28/2016)... ... 28, 2016 , ... Next week on May 5 at ... technologies for tissue stem cell counting and expansion to gene-editing scientists and other ... CRISPR-based Genome Engineering in Burlington, Massachusetts. , The attention of most gene-editing scientists ...
Breaking Biology Technology:
(Date:3/10/2016)... , March 10, 2016 ... market research report "Identity and Access Management Market by ... Compliance, and Governance), by Organization Size, by Deployment, by ... published by MarketsandMarkets, The market is estimated to grow ... Billion by 2020, at a Compound Annual Growth Rate ...
(Date:3/8/2016)... RALEIGH, N.C. , March 8, 2016 /PRNewswire/ ... biometric sensor technology, today announced it has secured ... led by GII Tech, a new venture fund ... LLC, with additional participation from existing investors TDF ... use the funds to continue its triple-digit growth ...
(Date:3/2/2016)... DUBLIN , March 2, 2016 /PRNewswire/ ... the addition of the "Global Biometrics ... to their offering. --> ... the "Global Biometrics as a Service ... --> Research and Markets ...
Breaking Biology News(10 mins):